BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3794548)

  • 1. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.
    Golper TA; Feingold KR; Fulford MH; Siperstein MD
    J Lipid Res; 1986 Oct; 27(10):1044-51. PubMed ID: 3794548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cholesterol metabolism in experimental nephrotic syndrome.
    al-Shurbaji A; Humble E; Rudling M; Lindenthal B; Berglund L
    Lipids; 1998 Feb; 33(2):165-9. PubMed ID: 9507238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia.
    Golper TA; Swartz SH
    Metabolism; 1982 May; 31(5):471-6. PubMed ID: 7078427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid metabolism in daunomycin-induced nephrotic rats (5)].
    Gomikawa S; Inagaki O; Mori H; Fujita Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):985-93. PubMed ID: 2263029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs.
    Kwong LK; Feingold KR; Peric-Golia L; Le T; Karkas JD; Alberts AW; Wilson DE
    Diabetes; 1991 Dec; 40(12):1630-9. PubMed ID: 1756903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.
    Vaziri ND; Liang KH
    Kidney Int; 1995 Dec; 48(6):1979-85. PubMed ID: 8587261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
    Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
    Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.
    Patel DD; Knight BL
    Eur J Biochem; 1985 Nov; 153(1):117-23. PubMed ID: 4065145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of plasma mevalonate in rats and humans.
    Kopito RR; Weinstock SB; Freed LE; Murray DM; Brunengraber H
    J Lipid Res; 1982 May; 23(4):577-83. PubMed ID: 7097123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of mevalonate in the hypercholesterolemia seen in experimental chronic renal failure.
    Subang MC; Stewart-Phillips JL; Pappu AS; Subang R; Gagnon RF
    Nephron; 1995; 69(2):151-4. PubMed ID: 7723897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative role of different embryonic tissues in mevalonate metabolism by sterol and nonsterol pathways. Relationship with enzyme activities of cholesterogenesis.
    Marco C; González-Pacanowska D; Segovia JL; García-Peregrín E
    Biochim Biophys Acta; 1986 Sep; 878(2):238-42. PubMed ID: 3019412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
    Sawamura M; Nara Y; Yamori Y
    J Biol Chem; 1992 Mar; 267(9):6051-5. PubMed ID: 1556116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of mevalonic acid, sterols and bile acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in the liver of rabbits with experimental hypercholesterolemia].
    Klimov AN; Poliakova ED; Vasil'eva LE; Denisenko TV; Dizhe EB
    Biokhimiia; 1987 Feb; 52(2):239-46. PubMed ID: 2882784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of cholesterol synthesis in rat liver as induced by 4-methyl-5-hydroxy valeric acid.
    Díaz-Zagoya JC; Hurtado ME; González J
    Experientia; 1976 Sep; 32(9):1138-40. PubMed ID: 971744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic cholesterogenesis by polar steroids accumulated after cholesterol feeding.
    Aguilera JA; García-Molina V; Arce V; García-Peregrín E
    Biosci Rep; 1988 Apr; 8(2):155-62. PubMed ID: 3408811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
    Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thyroid hormone status on mevalonate metabolism in rats.
    Feingold KR; Wiley MH; MacRae G; Siperstein MD
    J Clin Invest; 1980 Oct; 66(4):646-54. PubMed ID: 7419712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid synthesis. VI. Regulation of cholesterol 7 alpha-hydroxylase by taurocholate and mevalonate.
    Pandak WM; Vlahcevic ZR; Chiang JY; Heuman DM; Hylemon PB
    J Lipid Res; 1992 May; 33(5):659-68. PubMed ID: 1619360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.
    Chmielewski M; Sucajtys E; Swierczynski J; Rutkowski B; Bogusławski W
    Mol Cell Biochem; 2003 Apr; 246(1-2):187-91. PubMed ID: 12841361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.